First in the World! Sungen Biomedical Obtains FDA's Clinical Trial Approval of IND SGC001 as An Emergency-use Antibody Drug for AMI
First in the world! Sungen Biomedical obtains FDA's clinical trial approval of IND SGC001 as an emergency-use antibody drug for AMIOn May 23rd, 2024, Eastern Standard Time, US Food and Drug Administr...
FIC! Sungen Biomedical's SGC001 Injection is Approved for Clinical Trials, Achieving Two Approvals Both in China and the United States!
On August 05, 2024, the world's first innovative drug SGC001 injection obtained the clinical trial implied approval from the Center for Drug Evaluation (CDE). The drug is developed by Beijing Sung...
We provide antibody drug, latest innovations in biology, new innovations in biology, recent innovations in biology, biomedical engineering innovation, biology innovation, etc. For more information about bispecific antibody, please feel free to contact us!
You must be logged in to post a comment.